ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Kirsten To Join NCI As Head of FCRF, AIDS Vaccine Development Thaddeus Domanski Dies

February 5, 1988

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Guidelines Published On Lung Cancer Treatment

February 28, 2003

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

In Brief: One More Committee Review Needed for L.A., Rhode Island; Animal Tests In Factories (?)

May 13, 1977

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984